Funded Tech Companies

Nacuity Pharmaceuticals

Headquartered in Fort Worth, Nacuity Pharmaceuticals has funding from Foundation Fighting Blindness, Maxim Group and Retinal Degeneration.

Company Overview

Contact Information

Company Background Information

Overview

Nacuity Pharmaceuticals is a clinical-stage leader in innovative treatments for oxidative stress. The company's powerful, targeted therapies aim to stop oxidative tissue damage, a driver of blinding eye diseases and a broad spectrum of serious chronic conditions. Nacuity has several highly differentiated clinical programs, including retinitis pigmentosa, cataract, and cystinosis. The company is pursuing near-term proof-of-concept data in all three programs.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

6/15/2022

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Halden Conner

        

Chief Financial Officer

Charles Lieser

        

Chief Scientific Officer

G. Michael Wall

        

Company Investors

• Foundation Fighting Blindness (Benjamin Yerxa)
• Maxim Group
• Retinal Degeneration

Browse more funded tech companies:

Naco | Nada

Share this article

About Our Venture Capital Transactions Database

The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary